Frontlight ResearchEarly access
Psoriatic arthritis trials in South Korea
2 of 3 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleKorea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis
- Where
- Seoul
- Age
- 2 years to 17 years
- People
- 10
- Run by
- Pfizer
See details and how to joinNCT05754710 - No phaseTaking peopleKorean College of Rheumatology Biologics and Targeted Therapy Registry
- Where
- Seoul
- Age
- 18 years and over
- People
- 10,000
- Run by
- Seoul National University Hospital
See details and how to joinNCT01965132